These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 826034)

  • 1. [Possibilities and limitatious of immunosuppressive therapy].
    Chlud K
    Verh Dtsch Ges Rheumatol; 1976; 4():470-6. PubMed ID: 826034
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive long-term therapy of autoimmune diseases in hematology].
    Nelius D; Stieglitz R
    Z Gesamte Inn Med; 1972 Jun; 27(11):480-3. PubMed ID: 4626749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of cytostatics, antimetabolites and antirheumatics in progressive inflammatory arthropathies].
    Chlud K
    Clin Ter; 1970 Sep; 54(6):489-94. PubMed ID: 5527646
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunosuppressive agents in rheumatology].
    Dorfamnn H; Dreyfus P
    Minerva Med; 1969 Nov; 60(94):4711-4. PubMed ID: 5307890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and limitations of immunosuppressive treatment in rheumatoid arthritis].
    Chlud K
    Reumatizam; 1972; 19(1):1-8. PubMed ID: 5023361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppresive therapy of progredient chronic polyarthritis using antimetabolites and cytostatics].
    Gross D; Enderlin M; Fehr K
    Schweiz Med Wochenschr; 1967 Oct; 97(40):1301-10. PubMed ID: 4968560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of immunosuppressive agents on nucleic acid and nucleotide metabolism in rheumatoid arthritis (experimental and clinical study)].
    Matulis AA; Mishkinite GA; Kurtinite GP; Tamakauskene GI; Snechkene LI
    Vopr Revm; 1974; (2):61-7. PubMed ID: 4409366
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current possibilities in the antiphlogistic and immunosuppressive therapy of progressive chronic polyarthritis].
    Tanner E; Klotz L; Seidel K
    Beitr Rheumatol; 1971; 16():143-72. PubMed ID: 4946260
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive agents in the basic therapy of visceral forms of rheumatoid arthritis in children].
    Kölle G; Stoeber E; Schöntag W
    Med Klin; 1972 Apr; 67(17):603-7. PubMed ID: 4624842
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1987 Feb; 29(734):21-4. PubMed ID: 3807813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of the inflammatory rheumatism by immunosuppressors].
    Lièvre JA
    Therapeutique; 1970 Apr; 46(4):403-5. PubMed ID: 5427193
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression in the treatment of rheumatoid arthritis. Basic principles and available substances.
    Andreis M
    Adv Clin Pharmacol; 1974; 6():81-8. PubMed ID: 4468718
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis].
    Kobayashi I; Imura S
    Ryumachi; 1973 Jan; 13(1):48-9. PubMed ID: 4726792
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppressive treatment in rheumatology].
    Tsenov IP
    Vutr Boles; 1976; 15(3):1-8. PubMed ID: 788339
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of rheumatic diseases with cytostatics. (Review)].
    Vojtísek O
    Fysiatr Revmatol Vestn; 1967 Dec; 45(6):360-8. PubMed ID: 4865459
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the critical evaluation of immunosuppressive therapy in progressive chronic polyarthritis].
    Otto W
    Z Gesamte Inn Med; 1969 May; 24(10):147-8. PubMed ID: 5807424
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems of immunosuppressive therapy as shown on the example of chronic progressive polyarthritis].
    Jesserer H
    Z Gesamte Inn Med; 1973 Mar; 28(5):68-70. PubMed ID: 4705899
    [No Abstract]   [Full Text] [Related]  

  • 18. [The conservative treatment of chronic inflammatory rheumatism].
    Schmied P; Van Rossum P; Fallet GH
    Schweiz Med Wochenschr; 1969 Jun; 99(26):933-41. PubMed ID: 4979403
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities and limitations of immunosuppressive therapy in rheumatoid arthritis].
    Gigante D; Teodori S
    Reumatismo; 1968; 20(6):616-30. PubMed ID: 5736642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Short report on the possibilities of an immunosuppressive treatment in pulmonary diseases].
    Morawetz F
    Wien Med Wochenschr; 1974 Oct; 124(40):584-6. PubMed ID: 4139821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.